4-101025890-C-CCATTGCTGT
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_000944.5(PPP3CA):c.1532_1540dupACAGCAATG(p.Asp511_Asn513dup) variant causes a conservative inframe insertion change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000944.5 conservative_inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP3CA | NM_000944.5 | c.1532_1540dupACAGCAATG | p.Asp511_Asn513dup | conservative_inframe_insertion | Exon 14 of 14 | ENST00000394854.8 | NP_000935.1 | |
PPP3CA | NM_001130691.2 | c.1502_1510dupACAGCAATG | p.Asp501_Asn503dup | conservative_inframe_insertion | Exon 13 of 13 | NP_001124163.1 | ||
PPP3CA | NM_001130692.2 | c.1376_1384dupACAGCAATG | p.Asp459_Asn461dup | conservative_inframe_insertion | Exon 12 of 12 | NP_001124164.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not provided Uncertain:1
This variant, c.1532_1540dup, results in the insertion of 3 amino acid(s) of the PPP3CA protein (p.Asp511_Asn513dup), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PPP3CA-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.